Transformation Therapy Inc - Medicare Mental Health Clinic in West Palm Beach, FL

Transformation Therapy Inc is a medicare enrolled mental health clinic (Clinic/center - Adult Mental Health) in West Palm Beach, Florida. The current practice location for Transformation Therapy Inc is 3668 Turtle Island Ct, West Palm Beach, Florida. For appointments, you can reach them via phone at (240) 605-2882. The mailing address for Transformation Therapy Inc is 3668 Turtle Island Ct, West Palm Beach, Florida and phone number is (240) 605-2882.

Transformation Therapy Inc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1467905166. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (240) 605-2882.

Contact Information

Transformation Therapy Inc
3668 Turtle Island Ct
West Palm Beach
FL 33411-6444
(240) 605-2882
Not Available

Mental Health Clinic Profile

Full NameTransformation Therapy Inc
SpecialityClinic/Center
Location3668 Turtle Island Ct, West Palm Beach, Florida
Authorized Official Name and PositionRose Coretta Merchant (PRESIDENT)
Authorized Official Contact2406052882
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Transformation Therapy Inc
3668 Turtle Island Ct
West Palm Beach
FL 33411

Ph: (240) 605-2882
Transformation Therapy Inc
3668 Turtle Island Ct
West Palm Beach
FL 33411-6444

Ph: (240) 605-2882

NPI Details:

NPI Number1467905166
Provider Enumeration Date07/28/2016
Last Update Date12/06/2019

Medicare PECOS Information:

Medicare PECOS PAC ID4183902729
Medicare Enrollment IDO20161101002635

News Archive

Diabetes increases mortality after myocardial infarction by oxidizing CaMKII enzyme

Diabetic patients are more than twice as likely to die from a heart attack as non-diabetic patients, but the mechanisms that underlie increased heart attack-related mortality in diabetic patients are unknown. High levels of the oxidized form of the protein CamKII (ox-CaMKII) have been linked to increased risk of sudden death after heart attack.

NIH awards Aestus $2M SBIR grant for clinical trials of treatment for chronic neuropathic pain

Aestus Therapeutics, Inc. announced that it has been awarded a $2 million Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH). The grant, from the NIH's National Institute of Neurological Disorders and Stroke (NINDS), will fund clinical trials of Aestus's novel, first-in-class treatment for chronic neuropathic pain.

New genetic discovery in megalencephalic leukoencephalopathy with subcortical cysts

White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.

K2M launches EVEREST Minimally Invasive Spinal System at SMISS Global Forum 2014

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.

18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with brain metastases

Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Using this amino acid tracer, researchers found that physicians could accurately differentiate the two types of lesions 83 percent of the time. Progression-free survival could also be predicted through evaluating the 18F-FDOPA imaging results.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Transformation Therapy Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1467905166NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM0850XClinic/center - Adult Mental Health (* (Not Available))Primary
261QM0855XClinic/center - Adolescent And Children Mental Health (* (Not Available))Secondary
314000000XSkilled Nursing Facility (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Transformation Therapy Inc acts as a billing entity for following providers:
Provider NameRose C Merchant
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1649470873
PECOS PAC ID: 7618063314
Enrollment ID: I20160126002155

News Archive

Diabetes increases mortality after myocardial infarction by oxidizing CaMKII enzyme

Diabetic patients are more than twice as likely to die from a heart attack as non-diabetic patients, but the mechanisms that underlie increased heart attack-related mortality in diabetic patients are unknown. High levels of the oxidized form of the protein CamKII (ox-CaMKII) have been linked to increased risk of sudden death after heart attack.

NIH awards Aestus $2M SBIR grant for clinical trials of treatment for chronic neuropathic pain

Aestus Therapeutics, Inc. announced that it has been awarded a $2 million Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH). The grant, from the NIH's National Institute of Neurological Disorders and Stroke (NINDS), will fund clinical trials of Aestus's novel, first-in-class treatment for chronic neuropathic pain.

New genetic discovery in megalencephalic leukoencephalopathy with subcortical cysts

White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.

K2M launches EVEREST Minimally Invasive Spinal System at SMISS Global Forum 2014

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.

18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with brain metastases

Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Using this amino acid tracer, researchers found that physicians could accurately differentiate the two types of lesions 83 percent of the time. Progression-free survival could also be predicted through evaluating the 18F-FDOPA imaging results.

Read more Medical News

› Verified 2 days ago

News Archive

Diabetes increases mortality after myocardial infarction by oxidizing CaMKII enzyme

Diabetic patients are more than twice as likely to die from a heart attack as non-diabetic patients, but the mechanisms that underlie increased heart attack-related mortality in diabetic patients are unknown. High levels of the oxidized form of the protein CamKII (ox-CaMKII) have been linked to increased risk of sudden death after heart attack.

NIH awards Aestus $2M SBIR grant for clinical trials of treatment for chronic neuropathic pain

Aestus Therapeutics, Inc. announced that it has been awarded a $2 million Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH). The grant, from the NIH's National Institute of Neurological Disorders and Stroke (NINDS), will fund clinical trials of Aestus's novel, first-in-class treatment for chronic neuropathic pain.

New genetic discovery in megalencephalic leukoencephalopathy with subcortical cysts

White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.

K2M launches EVEREST Minimally Invasive Spinal System at SMISS Global Forum 2014

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the launch of EVEREST® Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014 in Miami, Fla.

18F-FDOPA imaging can help distinguish radiation-induced lesions in patients with brain metastases

Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Using this amino acid tracer, researchers found that physicians could accurately differentiate the two types of lesions 83 percent of the time. Progression-free survival could also be predicted through evaluating the 18F-FDOPA imaging results.

Read more News

› Verified 2 days ago

Clinic/Center in West Palm Beach, FL

Rehab South Florida Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4460 Medical Center Way, West Palm Beach, FL 33407
Phone: 863-532-3151    
Salonia Psychotherapy
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1825 Forest Hill Blvd., #105, West Palm Beach, FL 33406
Phone: 954-650-6907    
Sunshine Of Tomorrow Behavioral Care Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7711 N Military Trl Ste 204, West Palm Beach, FL 33410
Phone: 561-914-4104    
Diosark, Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1546 42nd St, West Palm Beach, FL 33407
Phone: 561-840-1647    Fax: 561-840-6415
Crossroads Counseling Center Of The Palm Beaches
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1825 Forest Hill Blvd, Suite 105, West Palm Beach, FL 33406
Phone: 561-722-7084    Fax: 561-697-9925
Wellbeing Therapy Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7750 Okeechobee Blvd # 4-76, West Palm Beach, FL 33411
Phone: 772-678-0341    
Be Free Stay Free Family & Individual Therapy Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3626 Whitehall Dr Apt 206, West Palm Beach, FL 33401
Phone: 561-377-2373    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.